News and Press

Scientists from the University of Utah collaborated with the Utah-based Sethera Therapeutics to develop an “unexpected” enzymatic approach to therapeutic peptide design. The research team published their findings in Proceedings of the National Academy of Sciences (PNAS). Lead author Karsten Eastman and his colleagues describe how PapB – a naturally-occurring enzyme found in Paenibacillus polymyxa […]

A team of researchers from the University of Utah and Sethera Therapeutics has uncovered a powerful new way to build more stable and drug-like peptides, opening the door to medicines that could target diseases long considered “undruggable.” Their findings are published last week in the Proceedings of the National Academy of Sciences. In the paper

The 2025 Wilson Sonsini Entrepreneur and Investor Life Sciences Summit (E&I Summit), presented by BioUtah and the University of Utah Technology Licensing Office will feature an impressive line-up of distinguished speakers, national and local investors, and numerous Utah life sciences startups. Now in its 12th year, the E&I Summit convenes Utah’s life sciences leaders, entrepreneurs,

Sethera Therapeutics Appoints Biotech Pioneer Dr. Robert Langer to Head and Chair the Scientific Advisory Board and Brigadier General Larry Lunt to Board of Directors